Benefit Expectations and Neuroprotective Prescribing for Acute Ischemic Stroke in China
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Neuroprotective therapies are frequently used for acute ischemic stroke in China. We examined associations of neurologists’ self-rated familiarity, perceived importance, and benefit expectations with reported prescribing frequency.
Methods
A hospital-based quota survey recruited attending-level or senior neurologists involved in acute ischemic stroke care across mainland China from May 27 to July 16, 2025. High-frequency use was defined as prescribing neuroprotective therapy to at least 60% of patients. High familiarity and importance were ratings of 4 or 5 on 5-level scales; consistently high benefit expectations required ratings of 4 or 5 in all 4 scenarios. Modified Poisson generalized estimating equations estimated adjusted prevalence ratios (PRs) with hospital-clustered robust standard errors.
Results
Among 1982 neurologists from 251 hospitals, 1007 (50.8%) were men and 1745 (88.0%) practiced in tertiary hospitals. High-frequency use was reported by 1596 respondents (80.5%), high familiarity by 1006 (50.8%), and consistently high benefit expectations by 1290 (65.1%). Lower familiarity with high-frequency use was reported by 743 respondents (37.5%). High familiarity (adjusted PR, 1.053; 95% CI, 1.007–1.102), high perceived importance (adjusted PR, 1.294; 95% CI, 1.148–1.458), and consistently high benefit expectations (adjusted PR, 1.198; 95% CI, 1.131–1.269) were associated with high-frequency use after adjustment for demographic and professional characteristics.
Conclusions
Frequent self-reported neuroprotective prescribing coexisted with lower self-rated familiarity in a substantial subgroup. Familiarity, perceived importance, and benefit expectations were associated with prescribing frequency. These cross-sectional, class-level measures cannot establish prescribing appropriateness or causality. Studies linking drug-specific observed prescribing to indications and patient outcomes are needed.